TG Therapeutics Inc (TGTX)
36.71
+0.73
(+2.03%)
USD |
NASDAQ |
Apr 11, 16:00
36.70
-0.01
(-0.03%)
After-Hours: 20:00
TG Therapeutics Max Drawdown (5Y): 93.19% for March 31, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Chimerix Inc | 97.68% |
| ADMA Biologics Inc | 84.37% |
| Cara Therapeutics Inc | 99.17% |
| Ocular Therapeutix Inc | 90.94% |
| Ocugen Inc | 99.95% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -4.802 |
| Beta (5Y) | 2.139 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 100.6% |
| Historical Sharpe Ratio (5Y) | 0.2923 |
| Historical Sortino (5Y) | 0.6113 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.12% |